Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1871-1880 of 2762 for

Edit search filters
  1. Minimally Invasive Groin Dissection for Melanoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Phase II Trial of Standard Chemotherapy +Various Proton Beam Therapy (PBT) Doses for Unresectable Stage 2/3 Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Assessing Glutamine Metabolism in MGUS and Myeloma

    Rochester, MN

  4. Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

  5. Immune Monitoring and Immunotherapy in Myeloma

    Rochester, MN

  6. Phase II Single-arm Study of Tepotinib Combined with Cetuximab

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma

    Jacksonville, FL, Rochester, MN

  8. A Study of Using Geometrically Accurate Functional MRI to Enable Personalized Radiotherapy of Glioblastoma

    Scottsdale/Phoenix, AZ

  9. A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

    Jacksonville, FL, Rochester, MN

  10. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer

    Rochester, MN

.

Mayo Clinic Footer